Klivira
Request demo

Streamlining Pediatric Oncology CVS Caremark Integration with Klivira

Klivira specializes in automating the complex prior authorization workflows inherent in pediatric oncology CVS Caremark integration, ensuring timely access to critical treatments for childhood cancer patients.

Revenue cycle directors and prior authorization coordinators in pediatric oncology face unique challenges with PBMs like CVS Caremark. The urgency of childhood cancer treatments, coupled with the complexity of COG protocols and high-cost therapies, necessitates an efficient and precise prior authorization process. Klivira's platform is engineered to address these specific demands.

The Critical Landscape of Pediatric Oncology Prior Authorizations

Pediatric oncology involves highly specialized, often urgent, treatment regimens. Prior authorizations for these therapies require meticulous documentation and rapid turnaround, where delays can significantly impact patient outcomes. Our focus is on automating the submission and tracking for complex cases like COG-protocol chemotherapy, advanced radiation, and novel cellular therapies.

Key Prior Authorization Triggers for CVS Caremark in Pediatric Oncology

CVS Caremark, as a major PBM, requires prior authorization for a range of high-cost medications and advanced therapies crucial in pediatric oncology. Klivira streamlines the submission of necessary clinical evidence for these triggers, ensuring compliance with payer guidelines.

Common PA Triggers in Pediatric Oncology Requiring CVS Caremark Approval:

  • High-cost chemotherapy regimens, including those specified by Children's Oncology Group (COG) protocols.
  • CAR-T cell therapies and other advanced cellular immunotherapies.
  • Proton beam therapy and other sophisticated radiation oncology modalities.
  • Specialty pharmacy medications for targeted therapies or supportive care, managed under the pharmacy benefit.
  • Advanced diagnostic imaging (e.g., PET scans, functional MRI) often requiring medical benefit review.

Optimizing EMR and Payer Touchpoints with Klivira

Klivira integrates directly with leading EMRs (e.g., Epic, Cerner) using SMART on FHIR, capturing critical patient data from order types and clinical templates. For CVS Caremark, our platform leverages standard electronic prior authorization (ePA) channels, including NCPDP SCRIPT and X12 278, and supports Da Vinci PAS initiatives where applicable, ensuring accurate and efficient data exchange.

Adherence to Clinical Guidelines and Evidence-Based Care

Prior authorizations in pediatric oncology are heavily informed by established clinical guidelines from bodies such as NCCN, ASCO, and specific COG protocols. Klivira's system is designed to structure documentation to align with these evidence-based requirements, facilitating faster review and approval by CVS Caremark and reducing the administrative burden on your clinical staff.

Frequently asked questions

How does Klivira handle COG protocol-specific documentation for CVS Caremark PAs?

Klivira's platform is configured to extract and present the specific clinical data points required by COG protocols from your EMR. This structured data is then submitted to CVS Caremark via appropriate ePA channels, ensuring all necessary evidence for these complex regimens is included for review.

What EMR systems does Klivira integrate with for pediatric oncology prior authorizations?

Klivira offers robust integration capabilities with major EMR platforms, including Epic and Cerner, leveraging SMART on FHIR standards. This allows for seamless data flow from your existing clinical workflows directly into our prior authorization automation system.

Can Klivira manage both pharmacy and medical benefit PAs for CVS Caremark in pediatric oncology?

Yes, Klivira is designed to manage prior authorizations across both pharmacy and medical benefits. This includes specialty pharmacy medications managed by CVS Caremark (pharmacy benefit) and high-cost procedures or advanced imaging (medical benefit), providing a unified workflow for all PA needs.

How does Klivira ensure PHI security during CVS Caremark integrations?

Klivira adheres to stringent security protocols and is fully HIPAA-compliant. All ePHI transmitted during the prior authorization process with CVS Caremark is encrypted both in transit and at rest, ensuring the confidentiality and integrity of sensitive patient data.

What is the typical implementation timeline for Klivira's CVS Caremark integration in a pediatric oncology setting?

Implementation timelines vary based on the complexity of your existing EMR setup and specific workflow requirements. Our team works closely with yours to ensure a smooth, efficient deployment, typically ranging from a few weeks to a couple of months, minimizing disruption to your operations.

Related coverage

Other pediatric-oncology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo